Pulmonx
Lou Browne is an experienced sales professional with a diverse background in the pharmaceutical and medical device industries. Currently serving as the Executive Territory Manager and Field Sales Coach at Pulmonx Corporation, Lou has previously held significant roles at Bayer Pharmaceuticals as a Senior Sales Consultant and Field Sales Trainer, as well as at Roche as a Market Development Manager. Additional experience includes positions at Hologic, Inc. as a Senior Territory Manager and GYN Surgical Field Sales Trainer, and serving as a Regional Sales Trainer at Watson Pharmaceuticals. Lou holds a Bachelor of Science (B.S.) degree in Hotel Management from Penn State University, obtained between 1995 and 1999.
This person is not in any offices
Pulmonx
2 followers
Pulmonx has developed the Zephyr Endobronchial Valve, a minimally invasive treatment for COPD/emphysema. The one-time procedure is done by bronchoscopy and requires no cutting or incisions. During the procedure, on average 4 tiny valves are placed in the airways to block off the diseased parts of the lung which allows trapped air to escape until the lobe is reduced. Reducing hyperinflation allows the healthier parts of the lungs to expand and take in more air. This results in patients being able to breathe easier and have less shortness of breath.1